Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Geron Corporation
Geron Corporation
National Cancer Institute (NCI)
Bellicum Pharmaceuticals
Roswell Park Cancer Institute
Kiadis Pharma